Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
Butterfly Network (BFLY) Drops -24.8% in 30 Days After Strong Run

Butterfly Network (BFLY) Drops -24.8% in 30 Days After Strong Run

Key Takeaways

  • Butterfly Network (BFLY) shares fell roughly 24.8% over the last 30 days, from an adjusted closing price of $8.96 on September 30 to approximately $6.74 at the latest quote.
  • The pullback followed a powerful multi-month advance in which the stock had roughly tripled over the trailing year, leaving it vulnerable to profit-taking.
  • Third-quarter revenue of $32.6 million rose 52% year over year with a record 73% gross margin, yet shares slipped after the report.
  • A newly filed $150 million shelf registration and at-the-market program, softer international results, and moderating core point-of-care-ultrasound growth weighed on sentiment.
  • Butterfly Embedded revenue surged more than 1,000% to $11.1 million, but concentration risk tied to a few large partners remained a focus for investors.

Understanding Butterfly Network (BFLY) and Its Market Position

Butterfly Network is a digital health company that pioneered semiconductor-based, whole-body ultrasound using its proprietary Ultrasound-on-Chip technology. Its flagship devices — the iQ3, iQ+, and iQ+ Bladder — allow clinicians to perform imaging with a single handheld probe connected to a smartphone or tablet. The company pairs this hardware with cloud software and artificial intelligence, including the Compass AI enterprise workflow platform and the Butterfly Garden AI marketplace, and generates revenue through device sales, software subscriptions, and the licensing and co-development of its chip platform through the Butterfly Embedded program. Investors follow BFLY for its expansion beyond standalone devices into enterprise point-of-care ultrasound, embedded partnerships, and a planned Home & Community Care offering. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Performance: The Last 30 Days and Quarter

Over the last 30 days, BFLY declined approximately 24.8%, moving from a September 30 adjusted close of $8.96 to around $6.74. The move was not a straight line: shares spiked above $10 intraday in early October before steadily giving back ground through the month. Over the last quarter, the stock has traded in a wide range between roughly $6.58 and $10.21, with notable peaks in late September near $9.93 and again in early October. From its late-July level near $8.17, the current quote reflects a decline of roughly 17% to 18% over the trailing three months — a notable cooldown from a multi-month rally even as the shares remain sharply higher on a year-over-year basis.

What Drove the 30-Day Pullback

The 30-day decline reflects a combination of profit-taking and specific concerns that outweighed otherwise strong operating results. After a rally in which the stock had appreciated substantially over the trailing year, momentum cooled as investors locked in gains. Butterfly Network reported third-quarter results in late October that beat expectations — revenue of $32.6 million, up 52% year over year, with a company-record 73% gross margin — and management raised full-year revenue guidance to $123 million to $126 million. However, the report also disclosed a new $150 million universal shelf registration and at-the-market program, which renewed dilution concerns. International revenue declined 5% year over year, core point-of-care-ultrasound revenue grew only 5%, and iQ+ sales fell 9%. Management also indicated that fourth-quarter revenue guidance implies a potential sequential decline, and investors weighed concentration risk around the large Midjourney partnership that is driving much of the Embedded segment's growth. These factors pressured the stock even as the company achieved FedRAMP authorization, opening access to U.S. federal government purchasing.

Performance Over the Quarter and Shifting Narrative

Over the last quarter, BFLY's narrative shifted from rapid appreciation toward consolidation. The preceding rally was fueled by accelerating revenue growth, improving gross margins, a narrowing adjusted EBITDA loss, and enthusiasm around the Butterfly Embedded program — particularly the Midjourney co-development partnership — as well as enterprise Compass AI software adoption and the emerging AI-imaging theme. As those gains priced in elevated expectations, the stock became more sensitive to execution details. The recent pullback reflects investors reassessing the durability of growth amid slowing core business momentum, international softness, the timing and lumpiness of Embedded revenue, and the financing-related dilution risk. Despite the retreat, the shares remain well above year-ago levels, underscoring how much optimism had been embedded in the prior run-up. From what I see, this cooldown is a natural part of digesting prior gains.

What Investors Should Watch Next

Investors will likely monitor whether Butterfly can convert its enterprise and federal opportunities into sustained revenue. Key items include fourth-quarter results against the company's implied $31 million to $34 million revenue range, the commercial launch of its first Home & Community Care state program, and the cadence and lumpiness of Embedded revenue. The 2027 product roadmap — including the next-generation P5.1-based probe, the iQ Station cart platform, and the Apollo chip program — represents a potential catalyst, as does the company's shift toward larger institutional and enterprise customers internationally. Macro factors such as tariffs, AI-driven supply-chain constraints, and competitive pressure in point-of-care ultrasound also bear watching. Finally, the recently filed at-the-market program introduces potential dilution that investors may weigh against the company's path toward cash-flow breakeven and its $122 million cash position. This information is provided for context only and is not investment advice.

Using Tickeron AI Tools in My Analysis

In my research, I frequently turn to Tickeron AI Trading Bots to gauge how automated strategies are handling positions in volatile names like BFLY. The platform offers a useful perspective on market movements that complements my own review of fundamentals and technicals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BFLY

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BFLY sees MACD Histogram just turned negative

BFLY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 41 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BFLY as a result. In 73 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for BFLY entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in 187 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.956) is normal, around the industry mean (4.142). P/E Ratio (-21.966) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (16.556) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 6.17B. The market cap for tickers in the group ranges from 837 to 190.22B. ABT holds the highest valuation in this group at 190.22B. The lowest valued company is DHAI at 837.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -11%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was -18%. MXCT experienced the highest price growth at 15%, while CODX experienced the biggest fall at -50%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 50
Price Growth Rating: 64
SMR Rating: 89
Profit Risk Rating: 94
Seasonality Score: 16 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Industry
N/A
Address
1600 District Avenue
Phone
+1 781 557-4800
Employees
220
Web
https://www.butterflynetwork.com
Interact to see
Advertisement
Alphabet Inc. (GOOG) , the parent of Google, YouTube, and Google Cloud, is a common stock, not an exchange-traded fund. The central target of $400 is the arithmetic mean of current analyst price targets, which span a wide band from roughly $300 to $500, with the broad average near $397.
AAPL has shown stronger relative performance in recent weeks, holding near record highs while many artificial intelligence (AI)-focused tech stocks sold off. MSFT has lagged the market and now trades below its 50-day moving average amid concerns over heavy AI infrastructure spending.
GOOG declined roughly 20% over the past 30 days, falling from about $331 to around $264 per share. The sell-off was triggered by Alphabet's third-quarter 2026 report, which revealed slowing Search advertising growth and an earnings miss.
Bending Spoons reported third-quarter 2026 revenue of $780.22 million, up 125.1% year over year and above the roughly $745.86 million consensus estimate. Earnings per share (EPS) came in at $0.42, beating the $0.26 consensus estimate by $0.16.
Intel Corporation has delivered dramatically stronger relative price momentum over the past year, while SPY offers broad, diversified market exposure with far lower single-stock volatility. INTC's rally has been driven by a strategic turnaround under new leadership, backed by multi-billion-dollar investments from Nvidia, SoftBank, and the U.S. government.